PUBLIC CONTRACT · 2025

1637/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de R1100 - RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA] e R1101 - RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP;

Contract value: €8,622.40
Signed on: 17 July 2025
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11593452

PUBLISHED SUBJECT

WHO CONTRACTED

Parties involved

Contracting body: Unidade Local de Saúde da Região de Aveiro, E. P. E.
Awardee: LAB. ROVI
Place of performance: Portugal, Aveiro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: LAB. ROVI · Tax ID 980166705

HOW MUCH AND WHEN

Values and timeline

Contract price: €8,622.40
Procedure base price: €370,691.74
Total effective price: Not reported on Portal BASE
Publication date: 21 July 2025
Award date: 20 June 2025
Signing date: 17 July 2025
Performance period: 215 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: Not stated
Centralised procedure: Yes
Environmental criterion: No
Notice: Not stated
Procedure identifier: 7698594

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts